X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (128554) 128554
Newspaper Article (2169) 2169
Newsletter (985) 985
Book Chapter (849) 849
Magazine Article (553) 553
Book / eBook (328) 328
Transcript (90) 90
Government Document (75) 75
Web Resource (54) 54
Trade Publication Article (44) 44
Conference Proceeding (28) 28
Dissertation (28) 28
Publication (27) 27
Book Review (25) 25
Reference (16) 16
Journal / eJournal (11) 11
Streaming Video (10) 10
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (99699) 99699
male (54128) 54128
cardiac & cardiovascular systems (52196) 52196
female (49934) 49934
middle aged (37821) 37821
aged (31702) 31702
risk factors (27077) 27077
animals (21832) 21832
adult (21784) 21784
treatment outcome (21733) 21733
cardiovascular disease (21632) 21632
mortality (17826) 17826
cardiovascular diseases (16906) 16906
cardiovascular (15991) 15991
hypertension (14855) 14855
cardiology (13436) 13436
care and treatment (13421) 13421
pharmacology & pharmacy (13146) 13146
peripheral vascular disease (12097) 12097
diabetes (10863) 10863
risk (10748) 10748
medicine & public health (10672) 10672
drug therapy (10646) 10646
antihypertensive agents - therapeutic use (10548) 10548
heart failure (10480) 10480
research (10450) 10450
analysis (10339) 10339
health aspects (10206) 10206
time factors (9989) 9989
hypertension - drug therapy (9269) 9269
cardiovascular-disease (9244) 9244
abridged index medicus (9150) 9150
atherosclerosis (9136) 9136
therapy (8969) 8969
prevention (8898) 8898
surgery (8867) 8867
heart (8728) 8728
aged, 80 and over (8646) 8646
patients (8635) 8635
cardiovascular diseases - prevention & control (8471) 8471
follow-up studies (7967) 7967
blood pressure (7930) 7930
prospective studies (7872) 7872
cardiovascular system (7733) 7733
retrospective studies (7727) 7727
heart attacks (7706) 7706
studies (7693) 7693
myocardial-infarction (7487) 7487
disease (7382) 7382
inflammation (7265) 7265
medicine, general & internal (7256) 7256
cholesterol (7154) 7154
stroke (7038) 7038
medicine (6979) 6979
prognosis (6945) 6945
management (6836) 6836
respiratory system (6816) 6816
cardiovascular agents - therapeutic use (6769) 6769
cardiovascular agents (6750) 6750
risk assessment (6529) 6529
clinical trials (6364) 6364
drug therapy, combination (6327) 6327
cardiac patients (6235) 6235
rats (6205) 6205
medical research (6137) 6137
internal medicine (6007) 6007
diagnosis (5774) 5774
heart diseases (5762) 5762
research article (5714) 5714
electrocardiography (5686) 5686
cardiology and cardiovascular medicine (5634) 5634
endocrinology & metabolism (5610) 5610
statins (5599) 5599
blood pressure - drug effects (5472) 5472
oxidative stress (5397) 5397
prevalence (5387) 5387
ischemia (5316) 5316
cardiovascular diseases - etiology (5291) 5291
blood-pressure (5173) 5173
coronary heart disease (5151) 5151
double-blind method (5132) 5132
anti-arrhythmia agents - therapeutic use (5094) 5094
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (5090) 5090
review (5087) 5087
adolescent (5013) 5013
randomized controlled trials as topic (5012) 5012
double-blind (5008) 5008
hypoglycemic agents - therapeutic use (4918) 4918
cardiovascular diseases - drug therapy (4752) 4752
coronary-heart-disease (4731) 4731
acute myocardial-infarction (4691) 4691
physiological aspects (4661) 4661
diabetes mellitus (4641) 4641
lipids (4635) 4635
mice (4604) 4604
heart failure - drug therapy (4602) 4602
usage (4595) 4595
risk-factors (4571) 4571
proteins (4553) 4553
atrial fibrillation (4524) 4524
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (131) 131
Online Resources - Online (43) 43
Collection Dvlpm't (Acquisitions) - Vendor file (24) 24
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
St. Michael's Hospital - Stacks (7) 7
Scarborough Hospital - General (4) 4
Gerstein Science - Periodical Stacks (3) 3
Scarborough Hospital - Birchmount (3) 3
Scarborough Hospital - Online (3) 3
Toronto East General Hospital - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Providence Healthcare - Reference (2) 2
Providence Healthcare - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - Reserve desk (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Reference (1) 1
Gerstein Science - Reserve desk (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Microtexts (1) 1
Mt Sinai Hospital - Online (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Pharmacy (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Circulation Desk (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Pharmacy (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Online (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Sunnybrook Reference (1) 1
UofT at Mississauga - Sunnybrook Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (129338) 129338
German (1149) 1149
Russian (886) 886
French (822) 822
Spanish (746) 746
Japanese (407) 407
Italian (313) 313
Polish (157) 157
Portuguese (123) 123
Hungarian (85) 85
Dutch (81) 81
Czech (68) 68
Chinese (65) 65
Danish (49) 49
Swedish (44) 44
Turkish (43) 43
Norwegian (25) 25
Finnish (23) 23
Hebrew (15) 15
Ukrainian (14) 14
Bulgarian (12) 12
Romanian (11) 11
Croatian (10) 10
Serbian (6) 6
Arabic (5) 5
Icelandic (3) 3
Lithuanian (3) 3
Slovak (3) 3
Slovenian (3) 3
Afrikaans (1) 1
Bosnian (1) 1
Breton (1) 1
Indonesian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary prevention medications in these communities... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Circulation, ISSN 0009-7322, 07/2016, Volume 134, Issue 3, pp. 248 - 261
Vitamin K antagonists are commonly used by clinicians to provide anticoagulation to patients who have or are at risk of having thrombotic events. In addition... 
anticoagulants | atrial fibrillation | venous thromboembolism | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | ACTIVATED FACTOR-VII | ATRIAL-FIBRILLATION | IN-VITRO | THROMBIN GENERATION | DABIGATRAN ETEXILATE | PROTHROMBIN COMPLEX CONCENTRATE | SYMPTOMATIC VENOUS THROMBOEMBOLISM | PRACTICAL MANAGEMENT | PERIPHERAL VASCULAR DISEASE | STAGE RENAL-DISEASE | FACTOR XA INHIBITOR | Recombinant Proteins - therapeutic use | Plasma | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Thiazoles - therapeutic use | Factor VIIa - therapeutic use | Arginine - analogs & derivatives | Dabigatran - therapeutic use | Thiazoles - adverse effects | Pyridines - adverse effects | Rivaroxaban - adverse effects | Factor Xa - therapeutic use | Rivaroxaban - therapeutic use | Factor Xa - adverse effects | Pyrazoles - adverse effects | Pyridines - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Administration, Oral | Antithrombins - therapeutic use | Piperazines - therapeutic use | Dabigatran - antagonists & inhibitors | Piperazines - adverse effects | Factor Xa Inhibitors - therapeutic use | Hemorrhage - drug therapy | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Blood Coagulation Factors - therapeutic use | Arginine - adverse effects | Pyridones - therapeutic use | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Arginine - therapeutic use | Pyridones - adverse effects
Journal Article
Cardiovascular & hematological agents in medicinal chemistry, ISSN 1871-5257, 2006
Journal
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 611 - 621
Mortality and morbidity in acute coronary syndromes (ACSs), caused principally by plaque erosion or rupture leading to thrombus formation and myocardial ischemia, have been reduced by a combination of antithrombotic agents... 
Cardiovascular | WORKING GROUP | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | EUROPEAN-SOCIETY | ELEVATION MYOCARDIAL-INFARCTION | CONSENSUS DOCUMENT | PLATELET REACTIVITY | ATRIAL-FIBRILLATION | UNFRACTIONATED HEPARIN | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes
Journal Article
Mini-Reviews in Medicinal Chemistry, ISSN 1389-5575, 2013, Volume 13, Issue 2, pp. 163 - 193
.... This work resumes the available and up to date work done on members of the Piperaceae family and their uses for therapeutic purposes. Methods... 
Pharmacological actions | Piperaceae | Complementary medicine | Phytochemical constituents | Piper | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | LIPID-PEROXIDATION | ALZHEIMERS-DISEASE | LARVICIDAL ACTIVITY | LUNG CARCINOGENESIS | ORAL SUPPLEMENTATION | B16F-10 MELANOMA-CELLS | IN-VITRO | pharmacological actions | complementary medicine | HEALTHY-VOLUNTEERS | phytochemical constituents | CYTOTOXIC PYRIDONE ALKALOIDS | Anti-Infective Agents - toxicity | Central Nervous System Agents - therapeutic use | Plant Extracts - chemistry | Plant Extracts - toxicity | Antioxidants - chemistry | Obesity - drug therapy | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Cardiovascular Diseases - drug therapy | Humans | Platelet Aggregation Inhibitors - toxicity | Anti-Obesity Agents - therapeutic use | Anti-Obesity Agents - toxicity | Anti-Infective Agents - chemistry | Anti-Inflammatory Agents - therapeutic use | Platelet Aggregation Inhibitors - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Alkaloids - toxicity | Alkaloids - pharmacology | Central Nervous System Agents - chemistry | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Anti-Infective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Cardiovascular Agents - toxicity | Antioxidants - pharmacology | Cognition Disorders - drug therapy | Piper - chemistry | Cardiovascular Agents - pharmacology | Neoplasms - drug therapy | Antineoplastic Agents, Phytogenic - toxicity | Antioxidants - toxicity | Cardiovascular Agents - therapeutic use | Anti-Obesity Agents - chemistry | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Central Nervous System Agents - pharmacology | Platelet Aggregation Inhibitors - chemistry | Alkaloids - therapeutic use | Antineoplastic Agents, Phytogenic - pharmacology | Anti-Obesity Agents - pharmacology | Plant Extracts - therapeutic use | Alkaloids - chemistry | Central Nervous System Agents - toxicity | Cardiovascular Agents - chemistry
Journal Article
Postgraduate Medical Journal, ISSN 0032-5473, 12/2016, Volume 92, Issue 1094, pp. 726 - 734
An estimated 5.1 million Americans have chronic heart failure and this is expected to increase 25% by 2030. Heart failure is a clinical syndrome that evolves... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | METAANALYSIS | RANDOMIZED-TRIAL | IN-HOSPITAL MORTALITY | DYSFUNCTION | NATRIURETIC PEPTIDE | COMBINATION | EPIDEMIOLOGY | ROSUVASTATIN | URODILATIN | Vasodilator Agents - therapeutic use | Erythropoietin - therapeutic use | United States | Humans | Calcium Channel Blockers - therapeutic use | Heart Failure - physiopathology | Aminobutyrates - therapeutic use | Cardiotonic Agents - therapeutic use | Societies, Medical | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Isosorbide Dinitrate - therapeutic use | Cardiology | Platelet Aggregation Inhibitors - therapeutic use | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hematinics - therapeutic use | Fumarates - therapeutic use | Anticoagulants - therapeutic use | Amides - therapeutic use | Antihypertensive Agents - therapeutic use | Evidence-Based Medicine | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | American Heart Association | Stroke Volume | Cardiovascular Agents - therapeutic use | Hydralazine - therapeutic use | Atrial Natriuretic Factor - therapeutic use | Iron - therapeutic use | Benzazepines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Peptide Fragments - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Practice Guidelines as Topic | Heart failure | Care and treatment | Usage | Analysis | Americans | Diagnosis | Cardiac output | Health aspects | Evidence-based medicine
Journal Article
Journal of cardiovascular pharmacology and therapeutics, ISSN 1074-2484, 1996
Journal
Molecules (Basel, Switzerland), ISSN 1420-3049, 2016, Volume 21, Issue 3, p. 264
Nowadays, there are some molecules that have shown over the years a high capacity to act against relevant pathologies such as cardiovascular disease,... 
Lung diseases | Liver disorders | ROS | Curcumin | Bioavailability | Natural compound | Antioxidant | Cardiovascular diseases | Anti-inflammatory | Cancer | lung diseases | antioxidant | OXIDATIVE STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | natural compound | CHEMOPREVENTIVE AGENT CURCUMIN | cardiovascular diseases | ALLERGIC AIRWAY INFLAMMATION | INDUCED LIPID-PEROXIDATION | I CLINICAL-TRIAL | CHEMISTRY, MULTIDISCIPLINARY | HUMAN COLORECTAL-CANCER | TUMOR-NECROSIS-FACTOR | bioavailability | liver disorders | INDUCED PULMONARY-FIBROSIS | anti-inflammatory | cancer | GLUTATHIONE-S-TRANSFERASE | NF-KAPPA-B | curcumin | Neuroprotective Agents - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Biological Availability | Curcumin - chemical synthesis | Neurodegenerative Diseases - drug therapy | Cardiotonic Agents - therapeutic use | Cardiotonic Agents - chemical synthesis | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - isolation & purification | Antineoplastic Agents, Phytogenic - therapeutic use | Antineoplastic Agents, Phytogenic - chemical synthesis | Curcumin - therapeutic use | Curcumin - isolation & purification | Inflammation | Antioxidants - chemical synthesis | Neoplasms - drug therapy | Antioxidants - therapeutic use | Neuroprotective Agents - chemical synthesis | Animals | Cardiotonic Agents - isolation & purification | Neuroprotective Agents - isolation & purification | Antioxidants - isolation & purification | Anti-Inflammatory Agents - chemical synthesis | Plants, Medicinal | Antineoplastic Agents, Phytogenic - isolation & purification | Curcuma - chemistry
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2010, Volume 102, Issue 1, pp. 14 - 25
.... In addition, cytotoxic agents and targeted therapies used to treat cancer, including classic chemotherapeutic agents, monoclonal antibodies that target tyrosine kinase receptors, small molecule... 
DOXORUBICIN-INDUCED CARDIOTOXICITY | TRASTUZUMAB-RELATED CARDIOTOXICITY | ONCOLOGY | SPORADIC COLORECTAL ADENOMAS | VASCULAR-DISRUPTING AGENTS | TYROSINE KINASE INHIBITOR | N-ACETYLCYSTEINE | DAUNORUBICIN-INDUCED CYTOTOXICITY | HIGH-DOSE CHEMOTHERAPY | EARLY BREAST-CANCER | ATRIAL-FIBRILLATION | Atrial Fibrillation - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Patient Care Team | Atrial Fibrillation - physiopathology | Ventricular Dysfunction, Left - chemically induced | Flavonoids - therapeutic use | Cardiotonic Agents - therapeutic use | Venous Thromboembolism - prevention & control | Cardiovascular System - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Hypertension - chemically induced | Hypertension - prevention & control | Polyphenols | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - diagnosis | Heart - physiopathology | Cardiovascular Diseases - physiopathology | Stroke Volume - drug effects | Anticoagulants - therapeutic use | Cardiovascular System - drug effects | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiovascular Diseases - microbiology | Animals | Blood Coagulation - drug effects | Venous Thromboembolism - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenols - therapeutic use | Venous Thromboembolism - chemically induced | Heart - drug effects | Cardiovascular Diseases - chemically induced | Atrial Fibrillation - prevention & control | Antimitotic agents | Complications and side effects | Aging | Physiological aspects | Dosage and administration | Research | Cardiovascular diseases | Antineoplastic agents | Risk factors | Index Medicus | Review
Journal Article